The nurse is preparing to give a medication for pain. The label states that the drug is “lipid soluble.” How soon should the nurse expect to observe the effects of the drug?

Choice A reason: Drug-receptor binding either activates (agonists) or inhibits (antagonists) receptor activity, altering physiological responses. This is the primary effect, making it the correct choice for receptor interaction.

Choice B reason: Drugs do not permanently alter receptors non-responsive; they modulate activity temporarily. Non-responsiveness may occur with chronic use, but it’s not the primary effect, so this is incorrect.

Choice C reason: Preventing receptor action is specific to antagonists, not all drugs. drugs bind to receptors. Binding broadly affects activity, so this is incorrect for the general effect of receptor binding.

Choice D reason: Drugs do not give receptors new functions; they enhance or block existing ones. ones. Activity modulation is the key effect, making this incorrect for what occurs during binding.

Choice A reason: Drugs with a narrow therapeutic range, like digoxin, require plasma level monitoring to ensure concentrations remain within a safe and effective range. This prevents toxicity (e.g., arrhythmias) or subtherapeutic effects, as small dose changes can significantly alter blood levels, making monitoring critical for patient safety and efficacy.

Choice B reason: Intravenous administration does not inherently address the risks of a narrow therapeutic range. While it ensures rapid delivery, it increases toxicity risk due to immediate bioavailability. Monitoring plasma levels is more critical than the route to maintain safe and effective drug concentrations, making this choice less appropriate.

Choice C reason: Administering at intervals longer than the half-life may lead to subtherapeutic levels for drugs with a narrow therapeutic range, reducing efficacy. Consistent dosing and plasma level monitoring are needed to maintain steady-state concentrations within the therapeutic window, making this choice incorrect for managing such drugs.

Choice D reason: Teaching that maximum effects occur quickly is inaccurate for most narrow therapeutic range drugs, which often require steady-state concentrations over time. Without monitoring, toxicity or inefficacy risks increase. Patient education should focus on adherence and monitoring, not rapid effects, making this choice inappropriate.